FDA Inspection
AntellisAntellis – FDA Inspection, Apr 13, 2023
Record Details
This FDA Inspection record concerns Antellis, with an inspection on April 13, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 5003c9ca-ebbc-4377-bb2d-added6a9e987
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1202632
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.165(e)Test methods
- 21 CFR 211.165(e)Test methods
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.